Heart failure trials in Latvia

4 of 6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

  Where

  Riga

  Age

  18 years and over

  People

  754 worldwide

  Run by

  Sunnybrook Health Sciences Centre

  See details and how to joinNCT05427370
• Phase 3Taking people
  Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

  Where

  Daugavpils, Liepaja, Riga

  Age

  18 years and over

  People

  1,900 worldwide

  Run by

  Pharmacosmos A/S

  See details and how to joinNCT06929806 · EU 2024-519059-28-00
• Phase 2Not yet taking people in Latvia
  A Phase 2, randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of CRD-4730 in patients with heart failure with reduced ejection fraction (HFREF) (CALIBRATE-HF)

  Where

  Daugavpils, Riga

  Age

  18 years and over

  People

  369 worldwide

  Run by

  Cardurion Pharmaceuticals Inc.

  See details and how to join2025-525033-31-00
• Phase 4Taking people
  The role of meldonium and individualized physical activities in the treatment of patients with heart failure

  Where

  Riga

  Age

  18 years and over

  People

  200

  Run by

  Pauls Stradins Clinical University Hospital

  See details and how to join2023-509804-14-00